Prophylactic IABP Use in Protected PCI Reduces Infarction Size and Leads to More Complete Revascularization in Comparison to Rescue IAPB Use

在保护性经皮冠状动脉介入治疗(PCI)中预防性使用主动脉内球囊反搏(IABP)可减少梗死面积,并实现更完全的血运重建,优于抢救性IABP的使用。

阅读:1

Abstract

BACKGROUND: There is little data questioning the timing of intra-aortic balloon pump (IABP) implantation in non-cardiogenic shock patients undergoing high-risk percutaneous procedures. AIMS: We compared prophylactic IABP (P-IABP) implantation to an emergent, unplanned rescue use (R-IABP) in high-risk PCI. METHODS: Among 300 IAPB patients who were treated at Ulm University Heart Center, Germany, between 2012 and 2020, we retrospectively selected and analyzed data from 59 patients. The cohort was subdivided into 44 P-IABP and 15 R-IAPB patients who underwent protected PCI with an IABP. Patients with cardiogenic shock at baseline, Impella-pump or extra corporal membrane oxygenator (ECMO) were excluded. Both elective and emergency patients with acute coronary syndrome were included. RESULTS: Both groups showed no significant difference in the baseline characteristics. The achieved SYNTAX score reduction after PCI (delta SYNTAX) was higher in the P-IABP group (22.15 ± 10.31 points in the P-IAPB and 15.73 ± 10.13 points in the R-IABP group, p = 0.04). In addition, we observed lower highly sensitive Troponin T (hsTnT) peak values in the P-IAPB group after the intervention (2223.33 ± 3129.77 ng/L vs. 5823.85 ± 3885.35 ng/L, p = 0.001). P-IABP was associated with peak hsTnT values (p = 0.01). The 30-day mortality rates were not significantly different (p = 0.88). CONCLUSION: Patients in the prophylactic-IAPB group experienced a more complete revascularization measured with the delta SYNTAX score compared to those in the rescue-IAPB group. Moreover, peri-interventional infarct size measured by hsTnT release was significantly lower. Both findings indicate that P-IABP implantation in high-risk PCI should be preferred to rescue IAPB use.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。